Trial Profile
An Open Label, Randomized, Single-dose Crossover Study to Evaluate the Pharmacokinetic Interaction of Dapoxetine 30mg and Mirodenafil 50mg in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Dapoxetine (Primary) ; Mirodenafil (Primary)
- Indications Erectile dysfunction
- Focus Pharmacokinetics
- Sponsors SK Chemicals
- 02 Jul 2015 New trial record